Disability Benefits for Lymphoma

How SSA Evaluates Lymphoma Under Listing 13.05

SSA evaluates both non-Hodgkin and Hodgkin lymphoma under Blue Book listing 13.05, with different rules for each:

• Aggressive non-Hodgkin lymphoma (such as diffuse large B-cell lymphoma) meets the listing when it persists or recurs despite anticancer therapy. A first course of treatment that achieves remission does not meet the listing, but any relapse does.
• Indolent (slow-growing) lymphoma, such as follicular lymphoma, meets the listing when it requires more than one antineoplastic treatment regimen within a 12-month period. Watchful waiting alone does not meet the listing, but needing a second line of treatment within a year does.
• Hodgkin lymphoma meets the listing when it fails to achieve clinically complete remission, or when it recurs within 12 months of completing initial treatment.
• Mantle cell lymphoma is on SSA's Compassionate Allowances list, so those claims are fast-tracked for approval.
• Stem cell or bone marrow transplant — if your lymphoma is treated with a transplant, SSA considers you disabled for at least 12 months from the date of the transplant, and then evaluates any lasting effects, such as graft-versus-host disease.

What This Means in Practice

The key question is almost always how your lymphoma responded to treatment. SSA does not deny a claim just because a lymphoma is described as treatable. If your disease came back, never fully cleared, or required multiple treatment regimens in a year, you likely meet the listing, and even in remission the after-effects of chemotherapy and radiation may still support a claim.

Medical Evidence SSA Needs for a Lymphoma Claim

Lymphoma claims turn on documentation of the disease type and its response to treatment. SSA will look for:

• Biopsy and pathology reports establishing the diagnosis and the specific lymphoma type — aggressive versus indolent matters a great deal under this listing.
• Staging studies — PET and CT scans, bone marrow biopsy results, and staging notes from your oncologist.
• Complete treatment history — every chemotherapy regimen with start and end dates, radiation records, immunotherapy such as rituximab, and CAR-T or transplant records. Dates are critical because the listing asks whether a second regimen was needed within 12 months or whether relapse occurred within 12 months of finishing treatment.
• Response assessments — post-treatment PET/CT reports showing complete remission, partial response, persistent disease, or relapse.
• Transplant records if you received a stem cell transplant, including the transplant date and any graft-versus-host disease treatment.

Ongoing symptoms — fatigue, recurrent infections, neuropathy, and night sweats — should be documented at every oncology and primary care visit.

Qualifying Without Meeting the Lymphoma Listing

If your lymphoma reached remission after one course of treatment, you may still qualify through a residual functional capacity (RFC) assessment. Lymphoma treatment is grueling: multi-agent chemotherapy causes lasting fatigue, peripheral neuropathy, heart damage from anthracyclines, and lung damage from bleomycin, while radiation to the chest or neck can impair the thyroid, heart, and lungs. Many survivors also deal with a weakened immune system and cognitive changes that make sustained concentration difficult.

An RFC that limits you to sedentary work, restricts exposure to infection risks, or includes off-task time for fatigue can rule out your past jobs. From there, the medical-vocational grid rules take over: claimants age 50 or older limited to sedentary work, or 55 or older limited to light work, frequently qualify. During active treatment, the sheer number of infusion days, scans, and recovery days often makes full-time attendance impossible on its own — a point worth documenting carefully.

Tips for a Stronger Lymphoma Claim

These steps help lymphoma claims succeed:

• Build a treatment timeline. List every regimen with exact dates. The 12-month windows in listing 13.05 make dates decisive, and a clear timeline helps the examiner see that you meet them.
• Flag mantle cell lymphoma prominently on your application so SSA applies Compassionate Allowances fast-tracking.
• If you relapsed, say so clearly. Recurrence after therapy is the heart of this listing — make sure the scan or biopsy documenting relapse is in your file.
• Apply immediately after a transplant. The 12-month disability period starts at transplant, and benefits can continue if graft-versus-host disease or other complications persist.
• Keep reporting fatigue and infections to your doctors even in remission, so the record supports an RFC case if the listing is not met.